Literature DB >> 11642713

The Haber-Weiss cycle--70 years later.

W H Koppenol1.   

Abstract

The chain reactions HO* + H2O2 --> H2O + O2*- + H+ and O2*- + H+ + H2O2 --> O2 + HO* + H2O, commonly known as the Haber-Weiss cycle, were first mentioned by Haber and Willstätter in 1931. George showed in 1947 that the second reaction is insignificant in comparison to the fast dismutation of superoxide, and this finding appears to have been accepted by Weiss in 1949. In 1970, the Haber-Weiss reaction was revived by Beauchamp and Fridovich to explain the toxicity of superoxide. During the 1970s various groups determined that the rate constant for this reaction is of the order of 1 M(-1) s(-1) or less, which confirmed George's conclusion. The reaction of superoxide with hydrogen peroxide was dropped from the scheme of oxygen toxicity, and superoxide became the source of hydrogen peroxide, which yields hydroxyl radicals via the Fenton reaction, Fe2+ + H2O2 --> Fe3+ + HO- + HO*. In 1994, Kahn and Kasha resurrected the Haber-Weiss reaction again, but this time the oxygen was believed to be in the singlet (1delta(g)) state. As toxicity arises not from a Fenton-catalysed Haber-Weiss reaction, but from the Fenton reaction, the Haber-Weiss reaction should not be mentioned anymore.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642713     DOI: 10.1179/135100001101536373

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  78 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production.

Authors:  Pawel Mroz; Jayeeta Bhaumik; Dilek K Dogutan; Zarmeneh Aly; Zahra Kamal; Laiqua Khalid; Hooi Ling Kee; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  Cancer Lett       Date:  2009-04-05       Impact factor: 8.679

3.  Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

Authors:  De-Liang Zhang; Manik C Ghosh; Hayden Ollivierre; Yan Li; Tracey A Rouault
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

Review 4.  Contemporary evidence on the physiological role of reactive oxygen species in human sperm function.

Authors:  Stefan S Du Plessis; Ashok Agarwal; Jacques Halabi; Eva Tvrda
Journal:  J Assist Reprod Genet       Date:  2015-02-03       Impact factor: 3.412

5.  Immunolocalization of hypochlorite-induced, catalase-bound free radical formation in mouse hepatocytes.

Authors:  Marcelo G Bonini; Arno G Siraki; Boyko S Atanassov; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2006-11-22       Impact factor: 7.376

Review 6.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

7.  Copper redox cycling in the prion protein depends critically on binding mode.

Authors:  Lin Liu; Dianlu Jiang; Alex McDonald; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  J Am Chem Soc       Date:  2011-07-18       Impact factor: 15.419

Review 8.  Quality control of chemically damaged RNA.

Authors:  Carrie L Simms; Hani S Zaher
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

9.  Nitric oxide consumption through lipid peroxidation in brain cell suspensions and homogenates.

Authors:  Robert G Keynes; Charmaine H Griffiths; Catherine Hall; John Garthwaite
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

Review 10.  Reactive oxygen species-activated nanomaterials as theranostic agents.

Authors:  Kye S Kim; Dongwon Lee; Chul Gyu Song; Peter M Kang
Journal:  Nanomedicine (Lond)       Date:  2015-09-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.